Harvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...

Global markets are reacting prematurely to geopolitical shifts, according to macro strategist David Roche. He argues that recent oil and eq...

Twelve Indian companies announced over USD 1.1 billion in US investments across aerospace, defense, energy, and AI sectors at the SelectUSA...

Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...

Roche is set to acquire 89bio for up to $3.5 billion, gaining access to the promising liver disease drug pegozafermin. This move complement...

Swiss pharmaceutical giant Roche announced a $50 billion U.S. investment to expand R&D and manufacturing, countering Trump-era tariffs and ...

Roche has announced its acquisition of Telavant, a developer of a new treatment for inflammatory bowel diseases, for an initial $7.1 billio...

Roche Information Solutions India, the healthcare digital entity of the global pharmaceutical major, will be paying rentals of over ₹210 cr...

The pool of family shareholders, who previously owned 45.01% of the voting rights in Roche, were given the exemption by the Swiss takeover ...

Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...

On May 9, the NPPA issued a notification capping the price of trastuzumab 440mg/50ml injections at Rs 55,812.29 per pack.

Last year, Swiss drug maker Roche, said it had signed a deal with Emcure Pharma to manufacture low-cost versions of its breast cancer drug.

Swiss drug major Roche, which is often at logger heads with Indian generic drugmakers over patent rights, has made a shift in its strategy.

Swiss pharmaceutical giant Roche said it has completed its $46.8 billion takeover of California-based biotech firm Genentech.

Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44% of biotech pioneer Genentech that it doesn’t already own, endin...

Biotechnology giant Genentech Inc. rejected a $43.7 billion buyout offer from its majority owner Roche on Wednesday but said it is open to ...

Pharmaceuticals maker Roche Holding AG said on Tuesday it is poised to complete its acquisition of Ventana Medical Systems Inc.